Skip to content

Evaluation of Kinesophobia in Patients With Metabolic Syndrome

Evaluation of Kinesophobia in Patients With Metabolic Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04123132
Enrollment
96
Registered
2019-10-10
Start date
2019-09-25
Completion date
2020-02-01
Last updated
2020-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kinesiophobia, Metabolic Syndrome

Keywords

kinesiophobia, metabolic syndrome, exercise

Brief summary

Metabolic syndrome (MS) is a public health problem characterized by central obesity, increased blood pressure and triglyceride levels, decreased blood HDL levels and the presence of insulin resistance (1).Kinesiophobia is a fear of irrational movement that develops because of its belief in susceptibility to injury and is associated with low levels of physical activity. Considering that exercise improves metabolic processes in people with MS, we aimed to evaluate the presence of kinesophobia in patients with MS. Patients aged 45-65 years diagnosed with metabolic syndrome and healthy controls will be included in the study. Patients with rheumatic and neurological diseases,history of trauma, gonarthrosis, lumbar disc hernia, previous fractures, fibromyalgia and those who have experienced pain for the last week will be excluded. The participants will be filled in the Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale, and the Tampa Kinesiophobia Scale. 48 patients with MS and 48 healthy participants will be included in the study.

Interventions

OTHERKinesiophobia

The presence of kinesiofobia in patients with metabolic syndrome

Sponsors

Erol Olcok Corum Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
45 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with metabolic syndrome

Exclusion criteria

* Patients with rheumatic disease * Patients with neurologic disease * Patients with history of trauma * Patients with gonartrosis * Pateints with fibromialgia

Design outcomes

Primary

MeasureTime frameDescription
Tampa Kinesiophobia Scale3 monthsPeople takes between 17-68 total a score. The score of the person shows high kinesiophobia on the scale

Countries

Turkey (Türkiye)

Contacts

Primary ContactDilek E Büyükşireci
dilekeker55@gmail.com+905439196253

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026